Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Jul;47(7):625–630. doi: 10.1136/jcp.47.7.625

EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA.

A Casonato 1, A Bertomoro 1, E Pontara 1, D Dannhauser 1, A R Lazzaro 1, A Girolami 1
PMCID: PMC502090  PMID: 8089218

Abstract

AIMS--To clarify the mechanisms involved in the development of EDTA dependent pseudothrombocytopenia, particularly the platelet receptors. METHODS--Platelets were measured in 33 patients with pseudothrombocytopenia, using different anticoagulants to collect blood samples (direct test). The results were compared with the counts obtained by adding patients' serum or immunoglobulins to normal blood samples (indirect test). The role of platelet function was explored using ASA, PGE1, and apyrase as platelet inhibitors. The contribution of platelet receptor/s was investigated using antigens to gpIb-IX and gpIIb-IIIa monoclonal antibodies. Immunoglobulin class was estimated by the ability of IgG, IgA, and IgM antibodies to prevent platelet clumping. RESULTS--Agglutinating antibodies were IgA in 40%, IgG in 30%, and IgM in 10% of patients studied. Both patients' serum and immunoglobulins induced platelet clumping in normal samples anticoagulated with EDTA (indirect test). This was prevented by incubation of blood samples at 37 degrees C and almost completely inhibited by the platelet inhibitors ASA, PGE1, and apyrase. Pseudothrombocytopenia was also entirely prevented by an antigen to gpIIb-IIIa monoclonal antibody that recognises fibrinogen and the von Willebrand factor binding site. Pseudothrombocytopenia was almost completely abolished after the addition of RGD peptide, the recognition sequence of cytoadhesive proteins. CONCLUSIONS--These findings suggest that EDTA dependent pseudothrombocytopenia is caused by agglutinating antibodies that recognise cytoadhesive receptors on platelet gpIIb-IIIa and that an efficient platelet metabolism is required.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. S., Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest. 1979 Nov;64(5):1393–1401. doi: 10.1172/JCI109597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berkman N., Michaeli Y., Or R., Eldor A. EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol. 1991 Mar;36(3):195–201. doi: 10.1002/ajh.2830360307. [DOI] [PubMed] [Google Scholar]
  3. Berning H., Stilbo I. Pseudothrombocytopenia and the haematology laboratory. Lancet. 1982 Dec 25;2(8313):1469–1470. doi: 10.1016/s0140-6736(82)91377-0. [DOI] [PubMed] [Google Scholar]
  4. Boehme W. M., Mahmood T., Phanuphak P. Pseudothrombocytopenia associated with vasculitis. Am J Med Sci. 1980 Mar-Apr;279(2):125–128. doi: 10.1097/00000441-198003000-00008. [DOI] [PubMed] [Google Scholar]
  5. Casonato A., Sartori M. T., de Marco L., Girolami A. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. Thromb Haemost. 1990 Aug 13;64(1):117–120. [PubMed] [Google Scholar]
  6. Castaman G., Ruggeri M., Rodeghiero F. EDTA-dependent pseudothrombocytopenia. Am J Hematol. 1992 Nov;41(3):226–226. doi: 10.1002/ajh.2830410316. [DOI] [PubMed] [Google Scholar]
  7. De Marco L., Girolami A., Zimmerman T. S., Ruggeri Z. M. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest. 1986 Apr;77(4):1272–1277. doi: 10.1172/JCI112430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Garcia Suarez J., Calero M. A., Ricard M. P., Krsnik I., Rus G. P., Perera F., Merino J. L. EDTA-dependent pseudothrombocytopenia in ambulatory patients: clinical characteristics and role of new automated cell-counting in its detection. Am J Hematol. 1992 Feb;39(2):146–148. doi: 10.1002/ajh.2830390215. [DOI] [PubMed] [Google Scholar]
  9. Gowland E., Kay H. E., Spillman J. C., Williamson J. R. Agglutination of platelets by a serum factor in the presence of EDTA. J Clin Pathol. 1969 Jul;22(4):460–464. doi: 10.1136/jcp.22.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Greipp P. R., Gralnick H. R. Platelet to leukocyte adherence phenomena associated with thrombocytopenia. Blood. 1976 Mar;47(3):513–521. [PubMed] [Google Scholar]
  11. Handa M., Titani K., Holland L. Z., Roberts J. R., Ruggeri Z. M. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem. 1986 Sep 25;261(27):12579–12585. [PubMed] [Google Scholar]
  12. Hynes R. O. Integrins: a family of cell surface receptors. Cell. 1987 Feb 27;48(4):549–554. doi: 10.1016/0092-8674(87)90233-9. [DOI] [PubMed] [Google Scholar]
  13. Imai H., Nakamoto Y., Miki K., Miyakuni T., Miura A. B. Pseudothrombocytopenia and IgA-related platelet agglutinin in a patient with IgA nephritis. Nephron. 1983;34(3):154–158. doi: 10.1159/000183001. [DOI] [PubMed] [Google Scholar]
  14. Imai H., Nakamoto Y., Miki K., Miyakuni T., Miura A. B. Pseudothrombocytopenia and IgA-related platelet agglutinin in a patient with IgA nephritis. Nephron. 1983;34(3):154–158. doi: 10.1159/000183001. [DOI] [PubMed] [Google Scholar]
  15. Kjeldsberg C. R., Hershgold E. J. Spurious thrombocytopenia. JAMA. 1974 Feb 11;227(6):628–630. [PubMed] [Google Scholar]
  16. Kjeldsberg C. R., Swanson J. Platelet satellitism. Blood. 1974 Jun;43(6):831–836. [PubMed] [Google Scholar]
  17. Niiya K., Hodson E., Bader R., Byers-Ward V., Koziol J. A., Plow E. F., Ruggeri Z. M. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood. 1987 Aug;70(2):475–483. [PubMed] [Google Scholar]
  18. Onder O., Weinstein A., Hoyer L. W. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with chelating agents. Blood. 1980 Aug;56(2):177–182. [PubMed] [Google Scholar]
  19. Payne B. A. EDTA-induced pseudothrombocytopenia. Recognizing a laboratory artifact. Postgrad Med. 1985 Jun;77(8):75–76. doi: 10.1080/00325481.1985.11699026. [DOI] [PubMed] [Google Scholar]
  20. Phillips D. R., Charo I. F., Scarborough R. M. GPIIb-IIIa: the responsive integrin. Cell. 1991 May 3;65(3):359–362. doi: 10.1016/0092-8674(91)90451-4. [DOI] [PubMed] [Google Scholar]
  21. Pierschbacher M. D., Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A. 1984 Oct;81(19):5985–5988. doi: 10.1073/pnas.81.19.5985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Plow E. F., D'Souza S. E., Ginsberg M. H. Consequences of the interaction of platelet membrane glycoprotein GPIIb-IIIa (alpha IIb beta 3) and its ligands. J Lab Clin Med. 1992 Aug;120(2):198–204. [PubMed] [Google Scholar]
  23. Pytela R., Pierschbacher M. D., Ginsberg M. H., Plow E. F., Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science. 1986 Mar 28;231(4745):1559–1562. doi: 10.1126/science.2420006. [DOI] [PubMed] [Google Scholar]
  24. Shreiner D. P., Bell W. R. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood. 1973 Oct;42(4):541–549. [PubMed] [Google Scholar]
  25. Solanki D. L., Blackburn B. C. Spurious thrombocytopenia during pregnancy. Obstet Gynecol. 1985 Mar;65(3 Suppl):14S–17S. [PubMed] [Google Scholar]
  26. Veenhoven W. A., Thomas-van der Schans G. S., Nieweg H. O. Monoclonal immunoglobulins with affinity for platelets and their relationship to malignant lymphoma. Cancer. 1982 Jan 1;49(1):40–42. doi: 10.1002/1097-0142(19820101)49:1<40::aid-cncr2820490110>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  27. Veenhoven W. A., van der Schans G. S., Huiges W., Metting-Scherphuis H. E., Halie M. R., Nieweg H. O. Pseudothrombocytopenia due to agglutinins. Am J Clin Pathol. 1979 Dec;72(6):1005–1008. doi: 10.1093/ajcp/72.6.1005. [DOI] [PubMed] [Google Scholar]
  28. van Vliet H. H., Kappers-Klunne M. C., Abels J. Pseudothrombocytopenia: a cold autoantibody against platelet glycoprotein GP IIb. Br J Haematol. 1986 Mar;62(3):501–511. doi: 10.1111/j.1365-2141.1986.tb02962.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES